Compare Stocks: ATHX, SXTP, XRTX, and SILO

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATHX Athersys		$0.00	$0.01 ▼ $1.99	$833K	-0.9	1.77 million shs	848 shs
SILO Silo Pharma	$1.77 -0.2%	$3.16	$1.63 ▼ $13.20	$2.82M	0.66	186,125 shs	6,988 shs
SXTP 60 Degrees Pharmaceuticals	$1.17 +0.9%	$1.15	$0.84 ▼ $8.62	$4.12M	2.54	1.59 million shs	19,630 shs
XRTX XORTX Therapeutics	$1.74 +2.4%	$2.10	$1.59 ▼ $7.05	$3.16M	0.75	512,578 shs	27,414 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATHX Athersys	0.00%	0.00%	0.00%	0.00%	0.00%
SILO Silo Pharma	+2.91%	+0.57%	-31.40%	-69.27%	-85.53%
SXTP 60 Degrees Pharmaceuticals	+11.54%	+25.54%	+7.41%	-29.27%	-79.14%
XRTX XORTX Therapeutics	-8.60%	-4.49%	-12.37%	-20.67%	-60.91%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATHX Athersys		$0.00	$0.01 ▼ $1.99	$833K	-0.9	1.77 million shs	848 shs
SILO Silo Pharma	$1.77 -0.2%	$3.16	$1.63 ▼ $13.20	$2.82M	0.66	186,125 shs	6,988 shs
SXTP 60 Degrees Pharmaceuticals	$1.17 +0.9%	$1.15	$0.84 ▼ $8.62	$4.12M	2.54	1.59 million shs	19,630 shs
XRTX XORTX Therapeutics	$1.74 +2.4%	$2.10	$1.59 ▼ $7.05	$3.16M	0.75	512,578 shs	27,414 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATHX Athersys	0.00%	0.00%	0.00%	0.00%	0.00%
SILO Silo Pharma	+2.91%	+0.57%	-31.40%	-69.27%	-85.53%
SXTP 60 Degrees Pharmaceuticals	+11.54%	+25.54%	+7.41%	-29.27%	-79.14%
XRTX XORTX Therapeutics	-8.60%	-4.49%	-12.37%	-20.67%	-60.91%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATHX Athersys	0.00	N/A	N/A	N/A
SILO Silo Pharma	1.00	Sell	N/A	N/A
SXTP 60 Degrees Pharmaceuticals	2.00	Hold	$13.85	1,093.97% Upside
XRTX XORTX Therapeutics	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest ATHX, SXTP, XRTX, and SILO Analyst Ratings

Date	Company	Brokerage	Action	Rating
9/21/2026	SXTP 60 Degrees Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
9/21/2026	XRTX XORTX Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
8/21/2026	SILO Silo Pharma	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/1/2026	SILO Silo Pharma	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/24/2026	SXTP 60 Degrees Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/24/2026	XRTX XORTX Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 9/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATHX Athersys	$146K	0.00	N/A	N/A	($1.33) per share	0.00
SILO Silo Pharma	$70K	40.20	N/A	N/A	$7.10 per share	0.25
SXTP 60 Degrees Pharmaceuticals	$1.41M	2.90	N/A	N/A	($5.85) per share	-0.20
XRTX XORTX Therapeutics	N/A	N/A	N/A	N/A	$1.50 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATHX Athersys	-$72.53M	-$2.03	N/A	N/A	N/A	N/A	N/A	-223.03%	N/A
SILO Silo Pharma	-$4.23M	-$4.36	N/A	N/A	N/A	-6,726.39%	-81.75%	-66.35%	12/2/2026 (Estimated)
SXTP 60 Degrees Pharmaceuticals	-$7.36M	-$4.82	N/A	N/A	N/A	-650.21%	N/A	-136.81%	11/12/2026 (Estimated)
XRTX XORTX Therapeutics	-$2.66M	-$2.73	N/A	N/A	N/A	N/A	-137.85%	-108.16%	11/12/2026 (Estimated)

Latest ATHX, SXTP, XRTX, and SILO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/15/2026	Q2 2026	XRTX XORTX Therapeutics	N/A	-$1.05	N/A	-$1.05	N/A	N/A
8/14/2026	Q2 2026	SXTP 60 Degrees Pharmaceuticals	-$0.74	-$0.90	-$0.16	-$0.90	$0.21 million	$0.21 million
8/13/2026	Q2 2026	SILO Silo Pharma	-$0.32	-$0.76	-$0.44	-$0.76	$0.02 million	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATHX Athersys	N/A	N/A	N/A	N/A	N/A
SILO Silo Pharma	N/A	N/A	N/A	N/A	N/A
SXTP 60 Degrees Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
XRTX XORTX Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATHX Athersys	N/A	0.06	0.06
SILO Silo Pharma	N/A	5.36	5.36
SXTP 60 Degrees Pharmaceuticals	N/A	2.32	1.78
XRTX XORTX Therapeutics	N/A	3.58	3.58

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATHX Athersys	19.35%
SILO Silo Pharma	5.58%
SXTP 60 Degrees Pharmaceuticals	7.96%
XRTX XORTX Therapeutics	0.23%

Insider Ownership

Company	Insider Ownership
ATHX Athersys	0.03%
SILO Silo Pharma	3.63%
SXTP 60 Degrees Pharmaceuticals	1.68%
XRTX XORTX Therapeutics	6.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATHX Athersys	24	61.72 million	61.70 million	No Data
SILO Silo Pharma	3	1.59 million	1.53 million	Not Optionable
SXTP 60 Degrees Pharmaceuticals	3	3.52 million	3.46 million	Not Optionable
XRTX XORTX Therapeutics	N/A	1.82 million	1.69 million	Not Optionable

ATHX, SXTP, XRTX, and SILO Headlines

Recent News About These Companies

XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO(TM), Targeting USD$700M+ U.S. Gout Market Opportunity

September 19, 2026 | barrons.com

XORTX Therapeutics Shares Rise 12% On IND Submission Plan

September 19, 2026 | rttnews.com

XORT Targets FDA IND Filing For XRx-026 Gout Program; NDA Submission Planned Within A Year

September 18, 2026 | rttnews.com

XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity

September 18, 2026 | globenewswire.com

XORTX Therapeutics (NASDAQ:XRTX) Share Price Passes Above Two Hundred Day Moving Average - Should You Sell?

September 15, 2026 | americanbankingnews.com

XORTX Begins Clinical, Commercial Manufacturing Of XORLO For Gout Program; Shares Surge To 31%

September 11, 2026 | rttnews.com

XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™

September 10, 2026 | financialpost.comF

XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™

September 10, 2026 | globenewswire.com

XORTX Re-Engages IR Firm After TSXV Delisting to Bolster Nasdaq-Focused Profile

September 8, 2026 | tipranks.com

XORTX Re-Engages Investor Relations Program

September 8, 2026 | financialpost.comF

XORTX Re-Engages Investor Relations Program

September 8, 2026 | globenewswire.com

XORTX Slips 10% As Investor Relations Program Is Terminated And Postponed

August 28, 2026 | rttnews.com

XORTX Announces Termination and Postponement of Investor Relations Program

August 28, 2026 | globenewswire.com

XORTX Therapeutics Files August Form 6-K Highlighting Stronger June 2026 Balance Sheet

August 17, 2026 | tipranks.com

XORTX Therapeutics Inc.

August 11, 2026 | barrons.com

XORTX Therapeutics Announces Resignation of Board Chairman Anthony Giovinazzo

August 4, 2026 | tipranks.com

XORTX Therapeutics Inc. annonce la démission d'Anthony Giovinazzo de son poste d'administrateur

August 2, 2026 | zonebourse.comZ

XORTX Therapeutics Inc.: XORTX Announces Director Resignation

August 1, 2026 | finanznachrichten.de

XORTX Announces Director Resignation

July 31, 2026 | financialpost.comF

XORTX Announces Director Resignation

July 31, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATHX, SXTP, XRTX, and SILO Company Descriptions

Athersys NASDAQ:ATHX

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. The company was founded in 1995 and is headquartered in Cleveland, Ohio.

Silo Pharma NASDAQ:SILO

$1.77 0.00 (-0.23%)

As of 11:03 AM Eastern

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

60 Degrees Pharmaceuticals NASDAQ:SXTP

$1.17 +0.01 (+0.86%)

As of 11:03 AM Eastern

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is headquartered in Washington, the District of Columbia.

XORTX Therapeutics NASDAQ:XRTX

$1.74 +0.04 (+2.35%)

As of 11:05 AM Eastern

Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers. Its product and solution portfolio for the enterprise data storage industry includes storage enclosures, integrated application platforms and high performance computing (HPC) data storage solutions. In April 2014, Seagate Technology PLC completed the acquisition of Xyratex Ltd.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ATHX, SXTP, XRTX, and SILO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ATHX, SXTP, XRTX, and SILO Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ATHX, SXTP, XRTX, and SILO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATHX, SXTP, XRTX, and SILO Company Descriptions

Athersys NASDAQ:ATHX

Silo Pharma NASDAQ:SILO

60 Degrees Pharmaceuticals NASDAQ:SXTP

XORTX Therapeutics NASDAQ:XRTX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ATHX, SXTP, XRTX, and SILO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ATHX, SXTP, XRTX, and SILO Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ATHX, SXTP, XRTX, and SILO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATHX, SXTP, XRTX, and SILO Company Descriptions

Athersys NASDAQ:ATHX

Silo Pharma NASDAQ:SILO

60 Degrees Pharmaceuticals NASDAQ:SXTP

XORTX Therapeutics NASDAQ:XRTX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools